Biosimilar Development Workshop
This workshop informs you of recent challenges in biosimilar development programmes with regard to quality, clinical and non-clinical issues.
-
This workshop informs you of recent challenges in biosimilar development programmes with regard to quality, clinical and non-clinical issues.50.1079831 8.6612577
| Wann |
27.03.2019 von 09:00 bis 17:00 |
|---|---|
| Veranstaltungsort | Frankfurt am Main, FLEMING´S Express Hotel Frankfurt |
| Stadt | Frankfurt am Main |
| Kontaktname | Dr. Henriette Wolf-Klein |
| Kontakttelefon | +49 6221 500-680 |
| Zielgruppe |
This workshop addresses the needs of healthcare professionals involved in the development, marketing authorisation and market access of biosimilars. A working knowledge of biosimilar development is a prerequisite. |
| Termin übernehmen |
vCal
iCal
|
This workshop gives you a thorough update on recent challenges in biosimilar development. Quality, clinical and non-clinical issues will be discussed with reference to recent cases.
It will also provide you with a toolbox for improving your biosimilar development and the ability to position your product.
It will also provide you with a toolbox for improving your biosimilar development and the ability to position your product.
Themen des Seminars:
- Critical quality attributes
- Abbreviated study programme: extrapolating indications
- Similarity testing and interchangeability
- Biobetter elements and cost-saving supplements
- Comparability to pre-change product and originator
- Abbreviated study programme: extrapolating indications
- Similarity testing and interchangeability
- Biobetter elements and cost-saving supplements
- Comparability to pre-change product and originator
Weitere Informationen über diesen Termin…
Programm
1903233.pdf
—
PDF document,
232 kB (237,571 bytes)
